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Abstract
Background: Pluripotent human embryonic stem cells (hESCs) have the potential to form every cell type
in the body. These cells must be appropriately characterized prior to differentiation studies or when
defining characteristics of the pluripotent state. Some developmentally regulated cell surface antigens
identified by monoclonal antibodies in a variety of species and stem cell types have proven to be side chains
of membrane glycolipids and glycoproteins. Therefore, to examine hESC surfaces for other potential
pluripotent markers, we used a panel of 14 lectins, which were chosen based on their specificity for a
variety of carbohydrates and carbohydrate linkages, along with stage specific embryonic antigen-4 (SSEA-
4), to determine binding quantitation by flow cytometry and binding localization in adherent colonies by
immunocytochemistry.
Results: Enriching cells for SSEA-4 expression increased the percentage of SSEA-4 positive cells to 98–
99%. Using enriched high SSEA-4-expressing hESCs, we then analyzed the binding percentages of selected
lectins and found a large variation in binding percentages ranging from 4% to 99% binding. Lycopersicon
(tomato)esculetum lectin (TL), Ricinus communis agglutinin (RCA), and Concanavalin A (Con A) bound to
SSEA-4 positive regions of hESCs and with similar binding percentages as SSEA-4. In contrast, we found
Dolichos biflorus agglutinin (DBA) and Lotus tetragonolobus lectin (LTL) did not bind to hESCs while Phaseolus
vulgaris leuco-agglutinin (PHA-L), Vicia villosa agglutinin (VVA), Ulex europaeus agglutinin (UEA), Phaseolus
vulgaris erythro-agglutinin (PHA-E), and Maackia amurensis agglutinin (MAA) bound partially to hESCs.
These binding percentages correlated well with immunocytochemistry results.
Conclusion: Our results provide information about types of carbohydrates and carbohydrate linkages
found on pluripotent hESC surfaces. We propose that TL, RCA and Con A may be used as markers that
are associated with the pluripotent state of hESCs because binding percentages and binding localization of
these lectins are similar to those of SSEA-4. Non-binding lectins, DBA and LTL, may identify differentiated
cell types; however, we did not find these lectins to bind to pluripotent SSEA-4 positive hESCs. This work
represents a fundamental base to systematically classify pluripotent hESCs, and in future studies these
lectins may be used to distinguish differentiated hESC types based on glycan presentation that accompanies
differentiation.
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Background
Ever since the isolation of human embryonic stem cells
(hESCs) in 1998 [1], the implications for their use in a
number of disease therapies have been highly regarded.
Additionally, these cells also find value as a model to
study basic human development. However, in all aspects
of ESC research, hESCs must first be appropriately defined
or characterized. One way to characterize hESCs is to uti-
lize the large number of glycoproteins and carbohydrates
existing on the cell surface as a way to delineate pluripo-
tent or differentiated cell types.
The most common hESC surface pluripotency markers are
the stage specific embryonic antigens -3 and -4 (SSEA-3, -
4) and tumor rejection antigens-1-60 and -1-81 (TRA-1-
60, -1-81). SSEA-3 and -4 are globoseries cell surface glyc-
oproteins that were first used to delineate embryological
changes in the developing mouse embryo [2,3]. Both of
these antigens were found to recognize sequential regions
of a mouse ganglioside epitope, with SSEA-4 (MC813-70
antibody) recognizing the terminal portion of the
sequence and SSEA-3 (MC613) recognizing the internal
region of he sequence. Thus, two antibodies were used to
define this unique embryonic antigen. In mouse embry-
onic stem cells (mESCs), SSEA-3 and -4 are expressed on
the 2–8 cell and morula stages of preimplantation
embryos and are also found on unfertilized oocytes; how-
ever, there is a loss of expression in the inner cell mass
(ICM) of mESCs [2,3]. Yet in hESCs, there is no expression
of SSEA-3 or -4 at the 2–8 cell or morula stage; however,
these are expressed on the ICM of human blastocysts and
on isolated hESCs [4]. It has been well documented that
these cell surface carbohydrates change both with devel-
opment and differentiation in vitro [5,6], but there may
be other undiscovered developmentally regulated cell sur-
face carbohydrates.
The hematopoetic field has numerous cell surface anti-
gens which have been identified that define various bone
marrow and blood stem cells, such as CD4, CD8, CD34,
CD38, CD44, CD45, c-kit, Mac-1, Muc -18, Lin, Sca-1, and
Thy-1 [7-11] and there has been some progress in identi-
fying other hESC surface markers that can be used both for
defining the pluripotent state and for cell sorting and cell
identification. Cell surface markers such as CD9 and
CD24 are presented on pluripotent hESC surfaces, while
gene expression analysis indicates such genetic markers as
REX1 [12], Cripto/TDGF1 [12], OCT-4 [13], DNMT3B
[13], LIN28 [13], Nanog [14], and others that can denote
pluripotency in hESCs [13]. Since carbohydrate antigens
on hESC surfaces could provide further potential markers
defining the pluripotent state, we targeted glycosylation
patterns on the cell surface of SSEA-4 enriched hESCs
using lectins to bind to these glycans. Lectins, carbohy-
drate binding proteins that recognize diverse sugar struc-
tures, have been extensively used to identify and
characterize cell surface glycosylation patterns. For exam-
ple, lectins have been used to investigate metastatic proc-
esses in many types of cancer [15-21] and to identify cell
types based on presentation of specific cell surface carbo-
hydrates [22-27]. Carbohydrate analysis using lectins has
also led to the delineation of embryologic developmental
stages in some species. For example, many developmen-
tally regulated glycans identified as lectin receptors on
mESCs are displayed on cell surfaces at the preimplanta-
tion and implantation stages of development. These
include Concanavalin A (Con A) defined by the hapten
methylmannoside [28], Peanut agglutinin (PNA) from
Arachis hypogaea defined by the hapten galactose [29],
Wheat Germ Agglutinin (WGA) from Triticum vulgaris
defined by hapten N-acetylglucosamine [30], Dolichos
biflorus agglutinin (DBA) defined by the hapten N-acetyl-
galactosamine [31], and Ricinus communis agglutinin
(RCA) defined by the hapten galactose or lactose [32].
These results suggest that glycans may be involved in cell-
cell interactions serving a specific developmental function
and also indicate that they can be used as markers to
define these stages of mouse embryogenesis.
In this study, we analyzed the pluripotent state of two
NIH approved hESC lines, BG01 and BG02. These cell
lines have previously been characterized for positive stain-
ing of the pluripotency markers TRA-1-60 and -1-81,
OCT-4, alkaline phosphatase, and SSEA-3 and -4 [33].
Lectin binding percentages on SSEA-4 enriched hESC sur-
faces were determined by flow cytometry using a panel of
14 lectins and SSEA-4, which enabled us to probe the sur-
face of pluripotent hESCs for a variety of carbohydrates
and carbohydrate linkages. Rosler et al showed that in
long-term culture, hESCs maintained pluripotency as
determined by measurement of a variety of characteristic
markers, including SSEA-4, TRA-1-60 and TRA-1-81 [34].
Moreover, there was a high correlation between expres-
sion of SSEA-4 and TRA-1-60 and -1-81, and the presence
of these markers correlated with undifferentiated
Structure of Stage Specific Embryonic Antigen 4 (SSEA4) Figure 1
Structure of Stage Specific Embryonic Antigen 4 
(SSEA4). SSEA-4, one of the most commonly used hESC 
surface pluripotency markers, is a globoseries glycolipid that 
is characteristically downregulated upon hESC differentiation.BMC Developmental Biology 2005, 5:15 http://www.biomedcentral.com/1471-213X/5/15
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morphology. Thus, we defined pluripotent hESCs as those
populations with 98–99% expression of SSEA-4, a devel-
opmentally regulated cell surface pluripotency marker
that is frequently used to delineate pluripotent hESCs
[1,4,5,35]. We were able to obtain this high level of SSEA-
4 expression by using magnetic bead sorting to select
SSEA-4 expressing cells. The SSEA-4 antibody (MC 813-
70) specifically recognizes a carbohydrate chain (Figure
1); thus, we analyzed a panel of lectins that are likely to be
presented on hESC surfaces in order to identify other
potential markers for pluripotent hESCs. Immunocyto-
chemistry using SSEA-4 and each of the 14 lectins was
analyzed to determine localization of lectin binding
within adherent hESC colonies and to validate binding
specificity of each lectin using appropriate competitive
sugars.
We found that a variety of lectins binding unique carbo-
hydrate moieties had distinct binding patterns. Our find-
ings demonstrate that there are many surface
carbohydrate antigens that could be exploited to further
characterize the pluripotent state of hESCs, and these
lectins may provide a source of unique markers with
which to characterize subpopulations that exist in colo-
nies of adherent hESCs.
Results
Carbohydrate analysis using flow cytometry
HESCs were trypsin passaged and selected for SSEA-4. It is
important to note that manual passaging would not be
feasible for flow cytometry studies, since atleast 250,000
single cells are needed per treatment for flow cytometry
analysis. After SSEA-4 enrichment using magnetic bead
sorting, 99.3 ± 0.31% of hESCs expressed SSEA-4 (Figure
2). To determine the presence and the percent binding of
the 14 chosen lectins on pluripotent hESC surfaces, both
karyotypically normal hESC lines (BG01 and BG02) were
analyzed using flow cytometry with the panel of lectins
and the pluripotency marker, SSEA-4. A broad range of
binding percentages was observed (Figure 3). The highest
binding percentages were detected using TL, RCA, ConA,
WFA, and SNA. Binding percentages for TL, RCA, and
ConA were similar to that of SSEA-4, ranging from 98–
99% of enriched hESCs. Figure 4B shows a shifted histo-
gram plot of TL as a representative of these high percent-
age binding lectins. WFA, PNA and SNA were also found
to bind to over 60% of hESCs.
Two lectins, DBA and LTL, did not bind to hESCs. Analysis
of DBA and LTL histograms showed no peak shifts using
these lectins (Figure 4C), and analysis of flow cytometry
plots also did not reveal any peak shifts (supplementary
data).
Some lectins were found to partially bind to hESC colo-
nies. These lectins revealed two distinct subpopulations of
cells that included a SSEA4+/lectin- population and a
SSEA4+/lectin+ population. Figure 4D shows a represent-
ative histogram plot of MAA which shows a large popula-
tion of cells that overlap the unstained control cells;
however, the arrow indicates another smaller population
SSEA-4 expression in enriched hESCs determined by flow  cytometry Figure 2
SSEA-4 expression in enriched hESCs determined by 
flow cytometry. The histogram plots of unstained, control 
hESCs (2A) and cells stained with SSEA-4 antibody after 
enrichment using magnetic bead sorting at day 0 (2B).
Quantitation of lectin binding on pluripotent hESC surfaces  with 14 different lectins Figure 3
Quantitation of lectin binding on pluripotent hESC 
surfaces with 14 different lectins. The percent of cells 
with specific carbohydrate expression as determined by flow 
cytometry using 14 different lectins. The data are means +/- 
SD of 3 independent assays of BG01 and BG02 hESC lines. 
hESCs from each line were stained with one of 14 lectins and 
SSEA-4 immediately following enrichment for SSEA-4 expres-
sion. abcd: Means with different letters are significantly differ-
ent, p < 0.05.BMC Developmental Biology 2005, 5:15 http://www.biomedcentral.com/1471-213X/5/15
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of cells that show a peak shift representing positive MAA
binding. Figure 4E shows the comparison of unstained
control cells to the shifted plot of MAA (Figure 4F) in
which there are two distinct populations of cells present:
a SSEA-4+/lectin- population containing the majority of
cells, and a smaller but still distinct SSEA-4+/lectin+ pop-
ulation indicated by the arrow. Lectins that bound in this
way included PHA-E, VVA, UEA, PHA-L, and MAA, and
these exhibited a large binding range varying from 58% to
13% binding of enriched SSEA-4 positive cells (Figure 3).
Carbohydrate analysis using immunocytochemistry
Both hESC lines, BG01 and BG02, were analyzed by
immunocytochemistry to determine localization of car-
bohydrates and to determine whether particular staining
patterns were present in adherent colonies maintained in
culture. Cells were either passaged manually or by
trypsinization and we did not observe obvious differences
in hESC colony staining patterns between these passage
methods. Immunocytochemistry results of all 14 lectins
supported our flow cytometry analysis. Five lectins (TL,
RCA, ConA, WFA, SNA, and HHL) bound throughout the
colonies without any localized patterns of binding. TL,
RCA, ConA, and WFA appeared to bind to cells that also
expressed SSEA-4. Figure 5A–C shows a hESC colony that
represents uniform lectin binding. RCA binding (Figure
5A) is shown throughout a colony that is SSEA-4 positive
(Figure 5B) and is also stained with DAPI nuclear stain
(Figure 5C).
We also observed interesting patterns of carbohydrate
expression for the lectins that showed two subpopula-
tions of cells when analyzed using flow cytomtery. VVA
bound to distinct regions of a SSEA-4 positive colony (Fig-
ure 5D–F), in contrast to the more uniform binding
described above. In Figure 5D the arrow shows a region
where there is no VVA binding, but this region is SSEA-4
positive as shown in Figure 5E. The DAPI nuclear stain of
this same colony is shown in Figure 5F. Figures 5G & H
show PHA-E binding in different colonies. In Figure 5G
there are two adjacent colonies with one colony showing
strong binding of SSEA-4 antibody (green) and little PHA-
E binding (red). The adjacent colony shows binding of
PHA-E but a lack of SSEA-4 antibody binding. In Figure
5H there is one colony that shows a streak of stacked cells
as determined by the high expression of DAPI staining in
the middle of the colony (depicted by arrow). These cells
are beginning to lose SSEA-4 antibody binding (green)
but have strong PHA-E binding (red). The rest of the col-
ony adjacent to this streak of cells is uniformly positive for
SSEA-4 but lacks PHA-E binding.
Using immunocytochemistry we also demonstrated that
DBA and LTL did not bind to hESC colonies. Figure 5I
shows a hESC colony which is SSEA-4 positive (green)
Flow cytometry histograms of lectin binding in unstained and  stained HESCs Figure 4
Flow cytometry histograms of lectin binding in 
unstained and stained HESCs. A-D shows histograms of 
SSEA-4 binding and representative lectins that were used in 
this study. To validate that double staining can be performed 
without signal interference, we determined that SSEA-4 
expression was not found in the FL1 channel. Figure 4A 
shows a histogram plot with the overlay image of SSEA4 
(black tracing) matching the histogram plot of unstained cells 
(grey fill). Figure 4B shows a positive peak shift in the histo-
gram overlay with Tomato lectin (TL) in black tracing and 
unstained cells (grey fill). Figure 4C shows lack of Lotus 
tetragonolobus lectin (LTL) (black tracing) binding in the histo-
gram overlay with unstained cells (grey fill). Figure 4D shows 
a histogram overlay with MAA (black tracing) binding and 
shows two peaks -one representing a large population that 
overlays unstained cells and a smaller population denoted by 
arrow that shows a smaller population of MAA+/SSEA4+ 
cells. Figure 4E shows plots of unstained hESCs, and Figure 
4F shows subpopulations of cells characterized as SSEA-4+/
MAA- or as SSEA-4+/MAA+ cells (arrow).BMC Developmental Biology 2005, 5:15 http://www.biomedcentral.com/1471-213X/5/15
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and is stained with DAPI nuclear stain (blue) but shows
only debris of the DBA lectin (red) with no regions of DBA
binding.
Validation of lectin binding
We used complementary competitive sugars that are
known to block lectin binding (listed in Table 1) to
Carbohydrate expression as determined by lectin binding using immunocytochemistry Figure 5
Carbohydrate expression as determined by lectin binding using immunocytochemistry. Figure 5A–C shows a 
hESC colony that represents uniform lectin binding. Ricinus Communis agglutinin (RCA) binding in red (5A) is shown throughout 
this SSEA-4 positive colony in green (5B). The DAPI nuclear stain image (blue) is also shown (5C). Other lectins showed partial 
binding patterns, such as Vicia Villosa agglutinin (VVA) binding (red), which is shown in a hESC colony (5D) that has uniform 
SSEA-4 antibody binding (green) (5E). Arrows denote distinct SSEA-4 positive regions lacking VVA binding. DAPI nuclear stain-
ing (blue) is also shown (5F). PHA-E binding is shown in two separate images in Figure 5G–H. In 5G there are two adjacent col-
onies, one that expresses strong binding of SSEA-4 antibody (green) and weak to no binding of PHA-E (red), and an adjacent 
colony showing binding of PHA-E without SSEA-4 antibody binding. (DAPI nuclear staining in blue). 5H, shows another colony 
with a streak of stacked cells (as determined by high DAPI expression, see arrow) in the middle of the colony that are begin-
ning to lose SSEA-4 expression (green), but have strong PHA-E binding (red). However, the rest of the colony adjacent to this 
streak of cells is uniformly positive for SSEA-4 but is lacking PHA-E binding. 5I shows lack of DBA binding and presence of 
SSEA-4 and DAPI staining. Images and scale bars: 5A-G) 20× magnification, 100 µm. H-I) 10× magnification, 100 µm.BMC Developmental Biology 2005, 5:15 http://www.biomedcentral.com/1471-213X/5/15
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validate lectin binding specificity. The concentrations
listed in Table 1 were all found to inhibit each lectin's
binding as detected by immunocytochemistry. As a repre-
sentative of competitive sugar inhibition, Figure 6 shows
blocking of RCA binding by addition of 200 mM galactose
(Figure 6A). In the absence of galactose, RCA binding is
evident (red, Figure 6B).
Discussion
This study is the first of which we are aware to use lectins
to probe the surface of hESCs in order to analyze carbohy-
drate presentation. To quantitate lectin binding percent-
ages on pluripotent hESC surfaces using flow cytometry,
we first enriched our colonies for SSEA-4 expression.
Using enriched pluripotent hESCs, we found a large bind-
ing percentage range for this chosen panel of 14 lectins.
Some lectins bound throughout the colonies of pluripo-
tent hESCs, and the carbohydrate moieties represented by
this group include alpha-linked mannose (Con A), galac-
tosyl(β 1–3) N-acetylgalactosamine (PNA), terminal
galactose and N-acetylgalactosamine (RCA), GalNAc β 4-
Gal (WFA), N-acetylglucosamine (TL) and sialic acid
alpha 2,6 GalNAc (SNA) and alpha-linked mannose resi-
dues only (HHL). These results indicate that there is high
expression of these carbohydrates with these particular
linkages on pluripotent hESC surfaces. As ConA can bind
both mannose and glucose moieties, we see greater lectin
binding of ConA as opposed to HHL, which specifically
binds only mannose residues. These lectins may be addi-
tional markers to denote pluripotent hESCs. Similarly,
WFA, PNA and SNA were found to bind to over 60% of
hESCs, suggesting that these lectins could be indicative of
a pluripotent phenotype as well; however, they do not
have binding percentages that correlate with SSEA-4
expression.
We also found that some lectins showed interesting par-
tial binding patterns. Two distinct populations of cells
were observed as determined by flow cytometry plot anal-
ysis and confirmed by immunocytochemistry using these
lectins and SSEA-4 antibody. These hESC populations
were identified as either SSEA-4+/lectin+ or SSEA-4+/lec-
tin- regions. Lectins showing this binding pattern
included PHA-L, VVA (see Figure 5D–F), UEA, PHA-E
(Figure 5G–H), and MAA. Table 1 shows their carbohy-
drate binding specificities.
As shown by immunocytochemistry of the representative
lectin, PHA-E, it appeared that some areas that were
beginning to lose expression of SSEA-4, show binding of
Table 1: Comparison of the specificity for monosaccharides and oligosaccharides of a panel of 14 biotinylated lectins used in 
immunocytochemistry and flow cytometry.
Lectin Origin Monosaccharide Specificity Inhibitor
Concanavalin A (Con A) Man or Glc 200 mM α -methylmannoside or α -methyl glucoside
Phaseolus vulgaris erythro-agglutinin (PHA-E) Gal galactose
Phaseolus vulgaris leuco-agglutinin (PHA-L) Gal galactose
Sambucus nigra agglutinin (SNA) Sialic Acid 500 mM lactose in acetic acid
Arachis hypogea peanut (PNA) Gal 200 mM galactose
Vicia villosa agglutinin (VVA) GalNAc 200 mM N-acetylgalactosamine
Maackia amurensis (MAA) Gal 200 mM lactose
Ricinus communis agglutinin (RCA) Gal 200 mM galactose or lactose
Wisteria floribunda agglutinin (WFA) GalNAc 200 mM N-acetylgalactosamine
Ulex europaeus agglutinin (UEA) Fuc 50–100 mM L-fucose
Lotus tetragonolobus lectin (LTL) Fuc 50–100 mM L-fucose
Dolichos biflorus agglutinin (DBA) GalNAc 200 mM N-acetylgalactosamine
Hippeastrum hybrid lectin (HHL) Man 100 mM mannose
Lycopersicon esculetum tomato (TL) GlcNAc Chitin Hydrolysate
Addition of competitive sugar inhibitor blocks lectin expres- sion as determined by immunocytochemistry Figure 6
Addition of competitive sugar inhibitor blocks lectin 
expression as determined by immunocytochemistry. 
Addition of 200 mM galactose can block RCA binding in a 
hESC colony as shown by lack of RCA binding (6A), but does 
not affect DAPI stain (blue). However, in the absence of 
galactose, uniform binding of RCA (red) was detected 6(B). 
6A-B) 20× magnification, 100 µmBMC Developmental Biology 2005, 5:15 http://www.biomedcentral.com/1471-213X/5/15
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the lectin (Figure 5G–H). A decrease of SSEA-4 expression
can occur even under the most stringent culturing condi-
tions and in this research, is important because it under-
scores the need for enriching for desired populations of
cells prior to experimentation and also supports the
hypothesis that cell-cell interactions are important in
carbohydrate presentation. As clusters of cells lose SSEA-4
expression, and therefore differentiate, new carbohydrates
are presented on the cell surface. Furthermore, these dif-
ferentiated cells could be indicative of progenitor subpop-
ulations existing in the colonies. For example, another
lectin in our study that was found to bind partially to col-
onies is UEA, which binds fucose moieties and has been
determined to be a marker for endothelial cells [16]. The
role these partially presented carbohydrates play was not
investigated in this study, but others have suggested that
certain carbohydrates may serve a developmental func-
tion. For example, Panin and colleagues have identified
O-fucose on epidermal growth factor-like repeats of
Notch, and elongation of O-fucose has been implicated in
the modulation of Notch signaling by Fringe [36,37].
Notch receptors and associated proteins are important in
a number of signaling pathways that direct cell fate deci-
sions, proliferation and apoptosis.
We also observed that two lectins, DBA and LTL, did not
bind hESCs. DBA binds primarily to α -linked N-acetylga-
lactosamine and LTL binds fucose moieties that are α -
linked to GlcNAc. These non-binding lectins suggest that
these particular carbohydrates and their associated link-
ages are either not present on pluripotent hESC surfaces or
if they are present, they have been modified and therefore
are not susceptible to lectin binding. Interestingly, how-
ever, PNA and WFA, which bind to a high percentage of
hESCs, bind to β -linked N-acetylgalactosamine. Thus, it
appears that the linkage of this carbohydrate is important.
Similarly, UEA binds to about 20% of our cells and recog-
nizes fucose moities like LTL. However, the linkages that
these lectins recognize are different and cause different
binding percent outcomes, further suggesting that the
linkage of these carbohydrates are important.
Developmentally regulated cell surface antigens have
been identified by monoclonal antibodies in a variety of
species and stem cell types. Many of these antigens have
proven to be side chains of membrane glycolipids and
glycoproteins. For example, the SB10 antigen found on
human mesenchymal stem cells was shown to be the acti-
vated leukocyte-cell adhesion molecule (ALCAM) that
possesses N-linked oligosaccharide side chains [38].
Muramatsu and colleagues discovered a protein called
embigin that has a developmentally regulated carbohy-
drate chain that is lost upon mouse embryogenesis [39].
Furthermore, other researchers showed that the mono-
clonal antibody GCTM-2, which binds to human
embryonic carcinoma cells and primate ES cells, recog-
nizes an epitope on a keratan sulfate proteoglycan
[40,41]. These studies have shown not only that carbohy-
drates on cell surfaces change with embryological devel-
opment but also that they can be used to identify different
types of stem cells. In addition, there are a number of car-
bohydrate epitopes that have been found on the mamma-
lian preimplantation embryo. Ofcourse, the tumor
rejection antigens and stage specific antigens have been
well characterized on human embryos [4], but there are
many others such as the TEC antigens (TEC1- TEC4), LeX,
LeY, CD46, CD55, and CD59. The TEC antigens have
been shown to recognize either the carbohydrate moiety
of embryoglycan or a developmentally regulated protein
epitope on both mouse and bovine preimplantation
embryos [42]. LeX [Galbeta1-4(Fucalpha1-3)GlcNAc] is
first detected on the blastomeres of the 8-cell stage of the
mouse embryo and LeY [Fucalpha1-2Galbeta1-
4(Fucalpha1-3)GlcNAc] is highly expressed on the surface
of the mouse blastocyst [43,44]. Also, studies of human
preimplantation embryos show that the glycosyl phos-
phatidylinositol anchored proteins CD46, CD55 and
CD59 are expressed on oocytes and plasma membrane
[45]. In this study, we analyzed glycans on the cell surface
of hESCs using a panel of 14 lectins and SSEA-4 antibody
and found that pluripotent hESC surfaces have a large
variety of surface carbohydrates that can be targeted for
marker sources.
Conclusion
This work represents a fundamental base to systematically
classify pluripotent hESCs, and in future studies these
lectins may be used to distinguish differentiated hESC
types based on carbohydrate presentation that accompa-
nies differentiation. It will be important to determine the
potential of these lectin positive cell types and to identify
the cell surface glycoproteins or glycolipids to which these
lectins bind. Because there are many different enzymes
that add or remove carbohydrate structures on cell sur-
faces, it will also be interesting to investigate the function
of some of these glycosyltransferases in both pluripotent
and differentiated hESCs.
Methods
Cell culture and passaging
NIH approved hESC lines BG01 and BG02 with normal
karyotypes were obtained from BresaGen, Inc. [33]. Cells
were grown in DMEM/F12 supplemented with 15% FCS
(HyClone), 5% knockout serum replacer, 1× non-essen-
tial amino acids, 20 mM L- Glutamine, 0.5 U/ml
penicillin, 0.5 U/ml streptomycin, 4 ng/ml FGF-2
(Sigma), (all from Gibco Invitrogen unless otherwise
labeled). Human ESCs were maintained on mitotically
inactivated primary mouse embryonic fibroblasts (MEF)
feeder layers for routine maintenance. Cells were grown inBMC Developmental Biology 2005, 5:15 http://www.biomedcentral.com/1471-213X/5/15
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100 cm tissue culture treated dishes (Falcon). Cells were
passaged every 3 days using either a pretreatment with 10
mg/ml collagenase for 2 minutes followed by 0.05%
trypsin for 1 minute or manual dissection with a fire
pulled Pasteur pipette [33]. Immunocytochemistry was
performed on routinely maintained adherent hESC colo-
nies, and flow cytometry was performed using routinely
maintained hESC colonies that were first enriched for
SSEA-4.
Enrichment of SSEA-4 positive cells
Cultures of hESCs were grown in 100 cm dishes and
trypsin passaged into single cell suspensions as described
above. Cells were incubated on ice for 15 minutes in 1:10
dilution of SSEA-4 (MC 813-70, Developmental Studies
Hybridoma Bank [DSHA]; Iowa City; in stain buffer (SB).
SB consisted of 0.5 ml 0.5 U/ml penicillin, 0.5 U/ml strep-
tomycin, 0.5 ml of 100 mM EDTA, 46.5 ml phosphate
buffered saline (PBS) and 2.5 ml fetal bovine serum
(FBS). After incubation 10 ml SB was added and cells were
resuspended and centrifuged at 3000 × g for 5 minutes.
Supernatant was removed, leaving the cell pellet intact,
and cells were washed again in SB and resuspended. After
centrifugation, a 1:4 dilution of secondary anti-mouse IgG
in stain buffer was added to the cell pellet, and the resus-
pended pellet was incubated on ice for 25 minutes. After
incubation 10 ml SB was added to wash the cell pellet, fol-
lowed by centrifugation (3000 × g) for 5 minutes. This
process was repeated two more times in 5 ml SB. Cells
were finally resuspended in 500 µl of SB before being
applied to a pre-washed magnetic bead column. The flow
through from the column was collected and saved for
counting, and the retained eluate was collected separately.
Both flow through and eluate were brought up to 5 ml in
SB after collection and counted [46]. Cells were then sub-
jected to flow cytometry. Flow cytometry results presented
here are from hESCs that were used immediately after the
enrichment procedure.
Flow cytometry
Cell surface antigen and carbohydrate expression of SSEA-
4+ enriched hESCs was assessed by indirect immunofluo-
rescence detected by flow cytometry to provide a quantita-
tive binding percentage of both SSEA-4 and lectin.
Human ESCs were harvested into single cell suspensions
using trypsinization as described above. Cells were
enriched for SSEA-4 as described above. Then, cells were
fixed in 2% paraformaldehyde in 1× PBS. After blocking
in 1% bovine serum albumin (BSA) for 30 minutes, cells
were placed in sterile conical tubes in aliquots of 500,000
cells each and double stained with one of the 14 lectins at
5  µg/ml and SSEA-4 in a 1:100 dilution. Cells were
washed 3 times with PBS and then stained with secondary
antibodies that included streptavidin -allophycocyanin
(1:250, BD Biosciences; Franklin Lakes, NJ;) for
recognition of biotinylated lectins and antigoat Mouse
IgG conjugated Alexa 488; (1:2000) for recognition of
SSEA-4. These secondary antibodies were chosen so that
there would not be overlap in the emission/excitation
wavelengths and so that double staining could be per-
formed. Unstained, enriched hESCs and enriched hESCs
stained with secondary antibodies alone were used as
controls.
Table 1 shows the chosen tested lectins, their commonly
abbreviated name, and the specificity of these lectins for
their respective monosaccharides to act as a quick refer-
ence guide and the concentration of hapten, or competi-
tive sugar, that was used to verify specificity of each lectin
for its carbohydrate. Specificity of each lectin has previ-
ously been described in detail by Cummings and col-
leagues [47]. Cytometry was performed using a Beckman
Coulter Cytomics FC 500 Flow Cytometer. Data analysis
was performed using the RXP Analysis Software by Beck-
man Coulter and Windows Multi Document Interface for
Flow Cytometry (WinMDI 2.8). Three independent assays
were carried out using both BG01 and BG02 hESC lines.
Immunocytochemistry
Immunocytochemistry was used to analyze the localiza-
tion of cell surface carbohydrate expression and SSEA-4
on routinely maintained adherent cultures of hESCs.
Human ESCs were harvested from 100 cm2 dishes by
either trypsin/collagenase dissociation or manual dissoci-
ation and fixed in 4% paraformaldehyde (Fisher Scien-
tific) in 1× PBS (Gibco) for 30 minutes. After blocking in
1% BSA solution for 30 minutes, cells were equally
divided into 4-well chamber slides which had previously
been plated with mitotically inactivated MEFs. Cells were
then double stained with one of 14 biotinylated lectins
(all lectins obtained from Vector Laboratories; Burlin-
game, CA; 10 µg/ml) and SSEA 4 (MC 813-70, Develop-
mental Studies Hybridoma Bank [DSHA]; Iowa
City;1:100) for 20 minutes at 37°C, followed by 3 washes
in PBS. Secondary antibodies included streptavidin conju-
gated Alexafluor 594 (Molecular Probes; Eugene, OR;
1:250 dilution) and antigoat Mouse IgG conjugated Alexa
488 (Molecular Probes; 1:2000 dilution). During staining
procedure, cells were kept at 37°C. Cells were washed
three times after secondary antibody incubation for 5
minutes in PBS. Cells were then post-stained with 5 ng/ml
DAPI (Sigma) to detect cell nuclei and washed overnight
in PBS. Controls of unstained cells were obtained by incu-
bation with secondary antibodies alone. All slides were
mounted and visualized using a Nikon TS100 inverted
microscope. Individual color channels were captured sep-
arately and merged in Adobe Photoshop.
Abbreviations used
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stage specific embryonic antigen-4 (SSEA-4)
inner cell mass (ICM)
N-acetylgalactosamine (GalNAc)
Fibroblast growth factor-2 (FGF-2)
mouse embryonic fibroblasts (MEF)
stain buffer (SB)
phosphate buffered saline (PBS)
fetal bovine serum (FBS)
bovine serum albumin (BSA)
Concanavalin A (Con A)
Phaseolus vulgaris erythro-agglutinin (PHA-E)
Phaseolus vulgaris leuco-agglutinin (PHA-L)
Sambucus nigra agglutinin (SNA)
Arachis hypogea peanut (PNA)
Vicia villosa agglutinin (VVA)
Maackia amurensis (MAA)
Ricinus communis agglutinin (RCA)
Wisteria floribunda agglutinin (WFA)
Ulex europaeus agglutinin (UEA)
Lotus tetragonolobus lectin (LTL)
Dolichos biflorus agglutinin (DBA)
Hippeastrum hybrid lectin (HHL)
Lycopersicon esculetum tomato (TL)
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